Drug
Abcl635
Abcl635: highest development phase Phase 1/2, developed by AbCellera Biologics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- AbCellera Biologics
Trials
| Drug | Phase | Indication |
|---|---|---|
| ABCL635 NCT07118891 | Phase 1/2 | Vasomotor Symptoms Associated With Menopause |
Latest
No recent events.
Follow Abcl635 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.